Skip to main
BLU
BLU logo

Bellus Health Inc (BLU)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy BLU Stock

About Bellus Health Inc (BLU)

BELLUS Health, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of cough hypersensitivity and other hypersensitization disorders. Its product BLU-5937, is being developed for the treatment of chronic cough and chronic pruritus, or chronic itch. The company was founded on June 17, 1993 and is headquartered in Laval, Canada.
Market cap$1.87B
Today's volume
Revenue (TTM)
Avg. daily volume5.36M
EBITDA (TTM)
Open
Price / earnings ratio-20.45x
Today's range
Debt / equity
52 week range$6.38 - $14.76
5 year debt / equity0.14x
Beta (LTM)0.78x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio
Ex-dividend date
Next earningsMay 12, 2023
Dividend payable date

Frequently Asked Questions (FAQ)

As of Jul 15, 2025, the market cap for BLU stock is $1.87B

The current P/E ratio for BLU stock is -20.45

The 52-week high for BLU stock is $14.76. The current BLU stock price $undefined is 100.00% below its 52-week high

The 52-week low for BLU stock is $6.38. The current BLU stock price $undefined has increased 100.00% from its 52-week low

No, the BLU stock does not pay dividends to its shareholders

How to buy BLU stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in BLU stock

    Navigate to the Explore page. Then, type BLU into the search bar. When you see BLU stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased BLU stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Bellus Health Inc Stock Earnings

The value each BLU share was expected to gain vs. the value that each BLU share actually gained.

BLU (BLU) reported Q1 2023 earnings per share (EPS) of -$0.20, missing estimates of -$0.18 by 11.11%. In the same quarter last year, BLU's earnings per share (EPS) was -$0.13. BLU is expected to release next earnings on 05/12/2023, with an earnings per share (EPS) estimate of $0.

Buy BLU Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.